Skip to main content
IMUX
NASDAQ Life Sciences

Key European Patent Granted for Immunic's Vidofludimus Calcium, Extending Exclusivity to 2038

Tom Rudovsky · Reported by EQS
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.27
Mkt Cap
$163.081M
52W Low
$0.506
52W High
$1.35
52W Position info
151% above low
Off High info
5.9% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

IMUX has more than doubled off its 52-week low of $0.506.

Summary

Immunic announced the European Patent Office has granted a key patent protecting relevant dosing regimens for its lead asset, vidofludimus calcium (IMU-838). This patent is expected to provide market exclusivity in Europe into 2038, with potential for extension to 2043, significantly strengthening the intellectual property portfolio for the late-stage drug candidate. While a similar patent was granted in the US in 2023, this European grant is a material positive development, reducing future generic competition risk and enhancing the long-term commercial value of vidofludimus calcium, which is currently in Phase 3 trials for multiple sclerosis. Investors will continue to monitor clinical trial progress and further IP developments.

At the time of this announcement, IMUX was trading at $1.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $163.1M. The 52-week trading range was $0.51 to $1.35. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: EQS.


Price Chart

Share this article

Copied!

IMUX - Latest Insights

IMUX
Nov 13, 2026, 7:12 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.71
Real-time Price: $7.03 info
Change: -$0.680 (-9%) info
Market Cap: $111.007M info
IMUX
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $7.03 info
Change: -$1.17 (-14%) info
Market Cap: $111.007M info
IMUX
Sep 09, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $7.03 info
Change: -$6.23 (-47%) info
Market Cap: $111.007M info
IMUX
Aug 11, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.10
Real-time Price: $7.03 info
Change: -$7.07 (-50%) info
Market Cap: $111.007M info
IMUX
Aug 11, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $7.03 info
Change: -$7.07 (-50%) info
Market Cap: $111.007M info